Post-Surgical Thyroid Ablation With Low or High Radioiodine Activities Results in Similar Outcomes in Intermediate Risk Differentiated Thyroid Cancer Patients

European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-12-0954
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Bioscientifica

Related search

rhTSH-aided Low-Activity Versus High-Activity Regimens of Radioiodine in Residual Ablation for Differentiated Thyroid Cancer

Nuclear Medicine Communications
MedicineNuclear MedicineRadiologyImaging
2013English

Clinical Outcomes of Patients With T4 or N1b Well-Differentiated Thyroid Cancer After Different Strategies of Adjuvant Radioiodine Therapy

Scientific Reports
Multidisciplinary
2019English

Re-Ablation I-131 Activity Does Not Predict Treatment Success in Low- And Intermediate-Risk Patients With Differentiated Thyroid Carcinoma

Endocrine
2016English

Clinicopathological Features Predict Outcomes in Patients With Radioiodine‐Refractory Differentiated Thyroid Cancer Treated With Sorafenib: A Real‐World Study

Oncologist
Cancer ResearchMedicineOncology
2020English

Differentiated Thyroid Cancer in Patients With Prolactinoma

Turkish Journal of Medical Sciences
Medicine
2016English

Innovation in the Post-Surgical Menagment of Differentiated Thyroid Carcinoma

Journal of the Siena Academy of Sciences
2012English

Exposure–response Analysis and Simulation of Lenvatinib Safety and Efficacy in Patients With Radioiodine-Refractory Differentiated Thyroid Cancer

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Surgeon-Performed Ultrasound Can Predict Differentiated Thyroid Cancer in Patients With Solitary Thyroid Nodules

Annals of Surgical Oncology
OncologySurgery
2010English

Well-Differentiated Thyroid Cancer: Thyroidectomy or Lobectomy?

CMAJ
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy